Fidelity Select Pharmaceuticals

Frequently Asked Questions About FPHAX

What does FPHAX invest in?

This fund typically allocates a minimum of 80% of its capital to entities involved in the pharmaceutical sector, encompassing activities from scientific discovery and development to manufacturing and distribution of various medicinal products. Its holdings include both domestic and international companies, with the portfolio primarily consisting of common equities. Investment decisions are guided by a thorough fundamental analysis, assessing aspects like a company's financial health, its standing within the industry, and broader market and economic trends. It operates as a non-diversified portfolio.

What is the expense ratio of FPHAX?

Fidelity Select Pharmaceuticals (FPHAX) charges an expense ratio of 0.67%. This is the annual fee deducted from fund assets to cover management and operations.

How big is FPHAX?

Fidelity Select Pharmaceuticals (FPHAX) manages $1.23B in total assets. AUM determines bid-ask liquidity and the fund's vulnerability to closure — funds below ~$50M are at higher risk of liquidation.

Is FPHAX actively managed or an index fund?

FPHAX's management style is described in the fund's prospectus. See the description on the Summary tab for the published strategy.

When was FPHAX launched?

Fidelity Select Pharmaceuticals (FPHAX) launched in June 2001 and is managed by Fidelity.

How has FPHAX performed?

FPHAX's total return — price change plus reinvested distributions — is charted at the top of this page. Switch the price chart to Total Return and pick a 1-year, 3-year, 5-year, or 10-year window to read the compound annual growth rate (CAGR) over each horizon.